Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Leczna – page 72

865 clinical trials in Leczna, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Leczna at a glance
865
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

865 trials in Leczna

Open in trial search

Dermatitis atopic

Not recruiting

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ODM-111
  • Sponsor:Orion Corporation

Osteoarthritis

Not recruiting

Study on Naproxen Sodium and Paracetamol for Patients with Knee Osteoarthritis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Naproxen Sodium
  • Sponsor:KRKA tovarna zdravil d.d. Novo mesto

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Study on Acute Lymphoblastic Leukemia Treatment in Children and Adolescents Using Bortezomib, Blinatumomab, and Methotrexate Combination

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Blinatumomab
  • Sponsor:Medical University Of Silesia Katowice Poland

Cardiac failure+4

Not recruiting

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:CDR132L
  • Sponsor:Cardior Pharmaceuticals GmbH

Crohn's disease

Not recruiting

Study of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD7798
  • Sponsor:AstraZeneca AB

Myelofibrosis+1

Not recruiting

Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Danazol
  • Sponsor:Sobi Inc.

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Colitis ulcerative

Not recruiting

Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Leczna

What the registry says about research in the country

01 Infectious Disease Prevention

Studies focusing on preventive vaccines and treatments for various infectious diseases, including research on meningococcal and pneumococcal vaccines for infants and toddlers, plus investigations into respiratory syncytial virus (RSV) prevention.

  • Meningococcal ACYW conjugate vaccine trials
  • Pneumococcal vaccine safety studies
  • RSV prevention research

Emphasis on immunogenicity and safety profiles in pediatric populations.

02 Gastrointestinal Disorders

Comprehensive research into inflammatory bowel conditions, with multiple trials examining new treatments for Crohn's disease and ulcerative colitis. Studies include novel therapeutic approaches and treatment targets.

  • Obefazimod efficacy studies
  • TEV-48574 clinical evaluation
  • Celiac disease symptom management

Focus on achieving both clinical and endoscopic remission in patients.

03 Critical Care Medicine

Investigations into treatments for severe conditions, including viral lung infections and acute bleeding management. Studies evaluate innovative therapies and emergency interventions.

  • Tozorakimab for respiratory support
  • Anticoagulation reversal studies
  • Burn treatment innovations

Research aimed at improving patient outcomes in urgent care situations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.